Labshake search
Citations for Tocris :
301 - 350 of 1115 citations for 7 Methoxy 9 methylphenazine 1 carboxylic acid since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2021Quote: ... or the AMPA-iGluR specific inhibitor 2,3-dioxo-6-nitro-7-sulfamoyl-benzo[f]quinoxaline (NBQX, cat. num. 373, Tocris). Drugs were dissolved in ESC complete media (no 2i ...
-
bioRxiv - Neuroscience 2022Quote: ... were recorded during the application of the competitive AMPA/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 20 μM, Tocris) and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5 ...
-
bioRxiv - Cell Biology 2022Quote: To observe chromosome alignment in fixed-cell experiments – with the advantage of taking high resolution images and easily selecting many cells for further analysis - cells were released from thymidine block for 7 hours before being treated for 2 hours with RO-3306 (10μM, Tocris) – to synchronise cells at the G2/M boundary - or with a 3-hour treatment with STLC (10μM ...
-
bioRxiv - Neuroscience 2019Quote: ... 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (“NBQX”, 100 mM in DMSO, Tocris Cat No 0373); D-2-amino-5-phosphonovalerate (“D-AP5” ...
-
bioRxiv - Cell Biology 2019Quote: ... HeLa FRT cells were released from thymidine block (40 h after siRNA treatment) for 7 hours before arresting at the G2/M boundary with RO-3306 treatment (10μM, Tocris) for 2 hours ...
-
bioRxiv - Neuroscience 2023Quote: ... slices were incubated in recording ACSF supplemented with 5 μM 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, Tocris, 1045) and 100 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-APV ...
-
bioRxiv - Neuroscience 2022Quote: ... drugs were bath applied at the following concentrations (in μM): 10 6-Cyano-7-nitroquinoxaline-2,3-dione disodium salt (CNQX, Tocris), 50 D-2-amino-5-phosphonopentanoic acid (D-APV ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... were recorded at −70mV in presence of 20□μM CNQX (6-Cyano-7-nitroquinoxaline-2,3-dione disodium, an AMPA receptor antagonist, Tocris) and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid ...
-
bioRxiv - Neuroscience 2024Quote: ... were recorded at −70mV in presence of 10□μM CNQX (6-Cyano-7-nitroquinoxaline-2,3-dione disodium, an AMPA receptor antagonist, Tocris) and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid ...
-
bioRxiv - Neuroscience 2019Quote: ... an excitatory amino acid transporter (EAATs) blocker DL-TBOA (100 µM, Tocris Bioscience, UK) was added to the bath ...
-
bioRxiv - Neuroscience 2021Quote: ... L-(+)-2-amino-4-phosphonobutyric acid (L-AP4, 50 μM, Tocris Bioscience, Bristol, UK) were diluted to the appropriate concentration from stock solutions and added to the bath through the perfusion system for 10 minutes before recordings ...
-
bioRxiv - Neuroscience 2021Quote: ... L-(+)-2-amino-4-phosphonobutyric acid (L-AP4, 50 μM, Tocris Bioscience, Bristol, UK) were diluted to the appropriate concentration from stock solutions and added to the Ames medium before recordings.
-
bioRxiv - Neuroscience 2022Quote: ... and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5; 50 μM, Tocris).
-
bioRxiv - Neuroscience 2020Quote: ... DL-2-Amino-5-phosphonopentanoic acid sodium salt (AP5, Cat. No. 3693, Tocris, UK), (-)-Bicuculline methochloride (Cat ...
-
bioRxiv - Neuroscience 2021Quote: ... Unilateral microinjections of either 0.239 µL vehicle (0.2% ascorbic acid in 0.9% saline; Tocris) or 0.239 µL 6-OHDA (3.6 µg ...
-
bioRxiv - Microbiology 2022Quote: ... 1ml of culture was incubated with the fluorescent D-amino acid HADA (Tocris Bioscience) at a final concentration of 250μM for 5 minutes ...
-
bioRxiv - Neuroscience 2022Quote: ... and L-2-amino-5-phosphonopentanoic acid (APV, an NMDA receptor blocker) from Tocris. APV ...
-
bioRxiv - Neuroscience 2023Quote: ... and 50 μM 2-amino-5-phosphonopentanoic acid (D-AP5; Tocris Bioscience, Cambridge, UK) to avoid spontaneous network activation ...
-
bioRxiv - Neuroscience 2024Quote: ... L-(+)-2-amino-4-phosphonobutyric acid (L-AP4, 50 mM, Tocris Bioscience, Bristol, UK) was added.
-
bioRxiv - Neuroscience 2022Quote: ... and 50 μM D,L-2-amino-5-phosphonovaleric acid (AP5, TOCRIS bioscience #0105). NH4Cl perfusions were done with 50 mM NH4Cl in substitution of 50 mM NaCl (pH 7.4) ...
-
bioRxiv - Cell Biology 2020Quote: The following soluble reagents were used to treat DCs in motility assays and for samples analyzed by western blotting: w-7 hydrochloride (Tocris), sto-609 acetate (Tocris) ...
-
bioRxiv - Neuroscience 2021Quote: ... 10 μM NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline) and 50 μM AP-5 (Tocris Bioscience, UK) were applied in the bath to block excitatory synaptic responses.
-
bioRxiv - Microbiology 2022Quote: ... 3 μl of 10 mM of NBD-(linezolid-7-nitrobenz-2-oxa-1,3-diazol-4-yl)-amino-D-alanine (NADA) (Tocris Bioscience) was added to the resuspension ...
-
bioRxiv - Neuroscience 2021Quote: ... 1,2-bis(2-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid (BAPTA, 50 µM, Tocris); and 1,2-Bis(2-aminophenoxy)ethane-N,N,N’,N’-tetra-acetic acid tetrakis (acetoxymethylester ...
-
bioRxiv - Neuroscience 2021Quote: ... 25 μM of d-(-)-2-amino-5-phosphonopentanoic acid (D-AP5, 0106, Tocris Bioscience, UK), and 10 μM of SR95531 (SR ...
-
bioRxiv - Neuroscience 2024Quote: ... Ex vivo gamma oscillations were induced by adding kainic acid (KA; Tocris Bioscience, Bristol, UK) at a concentration of 100 nM to the extracellular bath and were recorded using borosilicate glass microelectrodes (1,5-2,5 MΩ ...
-
bioRxiv - Neuroscience 2023Quote: ... and ASM concentration was kept constant at 10 μM: Valproic acid (Tocris, #1069-66-5), Levetiracetam (Tocris ...
-
bioRxiv - Neuroscience 2023Quote: ... N’-tetraacetic acid (BAPTA) was added to the intracellular solution and was obtained from Tocris Bioscience ...
-
bioRxiv - Neuroscience 2023Quote: ... 12-well plates at 7-8 x 105 cells/well in mTeSR1 with 10 µM rho-kinase inhibitor (Y- 27632; Tocris, 1254). The following day ...
-
bioRxiv - Neuroscience 2022Quote: ... to block ionotropic gamma-amino-butyric acid receptors (GABAARs) and 10 μM NBQX (1044, Tocris Biosciences) to inhibit α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) ...
-
bioRxiv - Neuroscience 2021Quote: ... 6R)-4-Amino-2-oxabicyclo [3.1.0] hexane-4,6-dicarboxylic acid disodium salt (LY379268, 100 µM, Tocris); calmidazolium chloride (CMZ ...
-
bioRxiv - Genetics 2019Quote: ... As negative controls for pluripotent mESC expression profiles we analyzed retinoic acid (RA; Tocris Biosciences, 0695)–treated mESCs and immortalized mouse embryonic fibroblasts (MEFs) ...
-
bioRxiv - Neuroscience 2023Quote: Susceptibility to seizures induced by the chemoconvulsant KA (kainic acid, Cat #0222, Tocris Bioscience, Minneapolis, MN) was tested in WT ...
-
bioRxiv - Neuroscience 2023Quote: ... and the other half with 10mg/kg of kainic acid (KA) (0222, Tocris, Minneapolis, MN, USA). Behavioral seizure severity was measured using the Racine scale ...
-
bioRxiv - Bioengineering 2023Quote: ... and then to TeSR-E6 supplemented with 0.1 µM TTNPB (a retinoic acid analogue, Tocris, 0761) for 13 days.
-
bioRxiv - Neuroscience 2024Quote: ... 2-amino-5-phosphonopentanoic acid (AP5) (cat. # 0106) and picrotoxin (cat. # 1128) were purchased from Tocris. Barium chloride (BaCl2-2H2O ...
-
bioRxiv - Neuroscience 2023Quote: ... Media were changed on days 9 and 11 with N2B27 with the same supplements as day 7 but with the addition of DAPT (10 mM; Tocris, 2634/10). At day 14 ...
-
bioRxiv - Neuroscience 2023Quote: ... Sham mice received a vehicle solution (240 nL of 0.2% ascorbic acid in 0.9% saline; Tocris, USA).
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid, a selective NMDA receptor antagonist, Tocris).
-
bioRxiv - Neuroscience 2024Quote: ... and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid, a selective NMDA receptor antagonist, Tocris).
-
bioRxiv - Neuroscience 2020Quote: ... The following agents were used: L-(+)-2-amino-4-phophonobutyric acid (L-AP4; 20μM; Tocris Bioscience, catalog #0103), D-(-)-2-amino-5-phophonopentanoic acid (D-AP5 ...
-
bioRxiv - Developmental Biology 2020Quote: ... and FGF2 (100 ng/ml, R&D) in the presence or absence of retinoic acid (0.1 µM, Tocris). For paraxial mesoderm differentiation ...
-
bioRxiv - Neuroscience 2023Quote: Susceptibility to seizures induced by the chemoconvulsant kainic acid (abbreviated as KA, Cat #0222, Tocris Bioscience, Minneapolis, MN) was assessed in B6 and F1D2 WT and Scn2aE/+mice of both sexes P41-44 days of age ...
-
bioRxiv - Neuroscience 2024Quote: ... a guide cannula (-0.94 AP, -2.85 ML) was implanted 7 days before administration of 0.2 μL KA (0222; Tocris, Minneapolis, MN; 1.5 mg/mL; -3.75 DV) in PBS ...
-
bioRxiv - Cell Biology 2020Quote: ... Cyclopiazonic-acid (CPA) and 2’(3’)-O-(4-Benzoylbenzoyl)adenosine-5’-triphosphate (BzATP) triethylammonium salt was purchased from Tocris Bioscience (Bristol ...
-
bioRxiv - Neuroscience 2019Quote: ... To block NMDA receptors we used D- (-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris, 10 μM final concentration). To block glycinergic inhibition ...
-
bioRxiv - Neuroscience 2020Quote: ... 20 μM 6,7-dinitroquinoxaline-2,3-dione (DNQX) and 20 μM D-(-)-2-amino-5-phosphopentanoic acid (D-AP5) (Tocris Bioscience) to block glycine- ...
-
bioRxiv - Neuroscience 2021Quote: ... our early pilot experiments assessed the impact of varying doses of Kainic Acid Monohydrate (KA, 0222, Tocris, Minneapolis, MN) on outcomes ...
-
bioRxiv - Biochemistry 2021Quote: Guanine unfolding experiments were performed by fluorescent dye assay using bis-ANS (4,4’-dianilino-1,1’-binaphthyl-5,5’-disulfonic acid, Tocris, Bristol, UK) as described previously(21 ...
-
bioRxiv - Neuroscience 2021Quote: ... synaptic GABA currents were recorded in perfusing aCSF containing the glutamate receptor antagonist kynurenic acid (3 mM, Tocris, Ellisville, MO). Recorded neurons were initially held at −70 mV for interneurons and −60 mV for GCs and SGCs and the response to 500 milli-second positive and negative current injections were examined to determine active and passive characteristics ...